Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

@article{Sikic1997ModulationAP,
  title={Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein},
  author={Branimir Sikic and G. A. Fisher and Bert L. Lum and J Jason Halsey and Lidija Beketi{\'c}-Ore{\vs}kovi{\'c} and Gang Chen},
  journal={Cancer Chemotherapy and Pharmacology},
  year={1997},
  volume={40},
  pages={S13-S19}
}
 Intrinsic and acquired multidrug resistance (MDR) in many human cancers may be due to expression of the multidrug transporter P-glycoprotein (Pgp), which is encoded by the mdr1 gene. There is substantial evidence that Pgp is expressed both as an acquired mechanism (e.g., in leukemias, lymphomas, myeloma, and breast and ovarian carcinomas) and constitutively (e.g., in colorectal and renal cancers) and that its expression is of prognostic significance in many types of cancer. Clinical trials of… CONTINUE READING
109 Citations
65 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 109 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 65 references

Absence of themdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A

  • AH Schinkel, E Wagenaar, L vanDeemter, CAAM Mol, P Borst
  • J Clin Invest
  • 1995

Disruption of the mousemdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

  • AH Schinkel, JJM Smit, +9 authors P Borst
  • Cell
  • 1994

Similar Papers

Loading similar papers…